http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1274176-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_910b2c2c248c55c9f6c36007b447ad2c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 1986-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1990-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1db7b930a5295ad10ce15826d8f480d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f05e5cc6424c7140ad61c5a1ce9597e9
publicationDate 1990-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-1274176-A
titleOfInvention Therapeutic compositions containing carboxylic azetidine derivatives
abstract ABSTRACT THERAPEUTIC COMPOUNDS Compound for use in a method for treatment of the human or animal body by therapy, characterised in that the compound is a carboxy azetidine derivative of the general formula I or a pharmaceutically acceptable salt, ester, amide, alkylamide, hydrazide or alkylhydrazide thereof:- I in which: X represents one or the groups CH2, CHR or CR2; Y represents one of the groups CHR, CR2 or CH.CO2H and Z represents one of the groups CH2, CHR, CR2 or CH.CHO2H; the or each R independently represents an alkyl, alkenyl or cycloalkyl group or an aryl or aralkyl group optionally substituted on the aryl nucleus by one or more of the same or different substituents selected from halogen atoms, alkyl groups and alkoxy groups; and one but only one of Y and Z must represent a CH.CO2H group. Therapeutic compositions containing such compounds are also described as are packs containing such compositions together with instructions for use in a method of treatment by therapy.
priorityDate 1985-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22326246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154092474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410446065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23694262
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426169444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421070379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421929059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21866494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431925421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448393953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11046239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364030

Total number of triples: 49.